Morgan Stanley Issues Pessimistic Forecast for MKS Instruments (NASDAQ:MKSI) Stock Price

MKS Instruments (NASDAQ:MKSIGet Free Report) had its target price cut by equities research analysts at Morgan Stanley from $150.00 to $147.00 in a research report issued to clients and investors on Friday,Benzinga reports. The firm currently has an “overweight” rating on the scientific and technical instruments company’s stock. Morgan Stanley’s target price would indicate a potential upside of 41.80% from the company’s current price.

Other analysts have also issued research reports about the company. The Goldman Sachs Group lifted their price objective on MKS Instruments from $128.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday. Needham & Company LLC decreased their price target on MKS Instruments from $156.00 to $145.00 and set a “buy” rating on the stock in a research note on Friday. Citigroup raised MKS Instruments from a “neutral” rating to a “buy” rating and set a $130.00 price target on the stock in a research note on Monday, January 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $140.00 price target on shares of MKS Instruments in a research note on Thursday. Finally, Benchmark reaffirmed a “buy” rating and issued a $142.00 price target on shares of MKS Instruments in a research note on Monday, November 18th. Three research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, MKS Instruments currently has a consensus rating of “Moderate Buy” and a consensus target price of $140.08.

Check Out Our Latest Report on MKS Instruments

MKS Instruments Stock Performance

Shares of NASDAQ MKSI opened at $103.67 on Friday. The company has a quick ratio of 2.21, a current ratio of 3.42 and a debt-to-equity ratio of 1.98. The business’s 50 day moving average is $110.77 and its two-hundred day moving average is $110.30. The company has a market cap of $6.98 billion, a P/E ratio of 230.38, a P/E/G ratio of 0.55 and a beta of 1.66. MKS Instruments has a 12 month low of $97.54 and a 12 month high of $147.40.

MKS Instruments (NASDAQ:MKSIGet Free Report) last issued its quarterly earnings results on Wednesday, February 12th. The scientific and technical instruments company reported $2.15 EPS for the quarter, topping the consensus estimate of $1.92 by $0.23. MKS Instruments had a return on equity of 15.79% and a net margin of 0.90%. On average, equities analysts expect that MKS Instruments will post 6.34 EPS for the current year.

Insider Transactions at MKS Instruments

In other news, Director Jacqueline F. Moloney sold 300 shares of the business’s stock in a transaction on Tuesday, December 10th. The stock was sold at an average price of $114.80, for a total transaction of $34,440.00. Following the completion of the sale, the director now owns 9,983 shares in the company, valued at $1,146,048.40. The trade was a 2.92 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Elizabeth Mora sold 275 shares of the company’s stock in a transaction dated Monday, December 2nd. The shares were sold at an average price of $113.41, for a total value of $31,187.75. Following the completion of the sale, the director now owns 17,659 shares of the company’s stock, valued at $2,002,707.19. This represents a 1.53 % decrease in their position. The disclosure for this sale can be found here. 0.46% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On MKS Instruments

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Steward Partners Investment Advisory LLC increased its holdings in MKS Instruments by 68.6% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 263 shares of the scientific and technical instruments company’s stock valued at $27,000 after purchasing an additional 107 shares during the last quarter. TD Private Client Wealth LLC bought a new stake in MKS Instruments in the fourth quarter valued at about $39,000. Blue Trust Inc. increased its holdings in MKS Instruments by 424.1% in the fourth quarter. Blue Trust Inc. now owns 414 shares of the scientific and technical instruments company’s stock valued at $45,000 after purchasing an additional 335 shares during the last quarter. Versant Capital Management Inc grew its stake in MKS Instruments by 58.0% in the fourth quarter. Versant Capital Management Inc now owns 433 shares of the scientific and technical instruments company’s stock valued at $45,000 after acquiring an additional 159 shares during the period. Finally, Wilmington Savings Fund Society FSB acquired a new position in MKS Instruments in the third quarter valued at about $50,000. Institutional investors own 99.79% of the company’s stock.

About MKS Instruments

(Get Free Report)

MKS Instruments, Inc provides foundational technology solutions to semiconductor manufacturing, electronics and packaging, and specialty industrial applications in the United States, Germany, China, South Korea, and internationally. It operates through Vacuum Solutions Division (VSD), Photonics Solutions Division (PSD), and Material Solutions Division (MSD) segments.

Further Reading

Analyst Recommendations for MKS Instruments (NASDAQ:MKSI)

Receive News & Ratings for MKS Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS Instruments and related companies with MarketBeat.com's FREE daily email newsletter.